These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 38571815)

  • 1. Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS).
    Heidarzadehpilehrood R; Pirhoushiaran M
    Noncoding RNA Res; 2024 Jun; 9(2):624-640. PubMed ID: 38571815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
    Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
    Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.
    Abdollahzadeh R; Daraei A; Mansoori Y; Sepahvand M; Amoli MM; Tavakkoly-Bazzaz J
    J Cell Physiol; 2019 Jul; 234(7):10080-10100. PubMed ID: 30537129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of dysregulated competing endogenous RNA networks in glioblastoma: A way toward improved therapeutic opportunities.
    Rahnama S; Bakhshinejad B; Farzam F; Bitaraf A; Ghazimoradi MH; Babashah S
    Life Sci; 2021 Jul; 277():119488. PubMed ID: 33862117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks.
    Aghajani Mir M
    Infect Genet Evol; 2024 Aug; 122():105613. PubMed ID: 38844190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis.
    Mu L; Sun X; Tu M; Zhang D
    Reprod Biol Endocrinol; 2021 Jan; 19(1):10. PubMed ID: 33446212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs.
    Li M; Zeng Z; Zhang A; Ye Q; Su S; Xia T
    Int J Gen Med; 2021; 14():8737-8751. PubMed ID: 34849014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review.
    Nasser JS; Altahoo N; Almosawi S; Alhermi A; Butler AE
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks.
    Zhou W; Zhang T; Lian Y; Zhang W; Yang M; Li Y; Wang L; Yan X
    Reprod Biomed Online; 2022 May; 44(5):777-790. PubMed ID: 35337736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ceRNAs in non-tumor female reproductive diseases†.
    Yang Y; Xiong Y; Pan Z
    Biol Reprod; 2023 Mar; 108(3):363-381. PubMed ID: 36355359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome.
    Li Y; Tan Y
    Comput Math Methods Med; 2021; 2021():9988347. PubMed ID: 34211581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing Endogenous RNAs (CeRNAs): Novel Network in Neurological Disorders.
    Tehrani SS; Ebrahimi R; Al-E-Ahmad A; Panahi G; Meshkani R; Younesi S; Saadat P; Parsian H
    Curr Med Chem; 2021; 28(29):5983-6010. PubMed ID: 33334276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer.
    Bai Q; Pan Z; Nabi G; Rashid F; Liu Y; Khan S
    Am J Cancer Res; 2022; 12(3):961-973. PubMed ID: 35411240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune dysfunction mediated by the competitive endogenous RNA network in fetal side placental tissue of polycystic ovary syndrome.
    Xie N; Wang F; Chen D; Zhou J; Xu J; Qu F
    PLoS One; 2024; 19(3):e0300461. PubMed ID: 38512862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing Endogenous RNA Networks in Glioma.
    Cen L; Liu R; Liu W; Li Q; Cui H
    Front Genet; 2021; 12():675498. PubMed ID: 33995499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tempol modulates lncRNA-miRNA-mRNA ceRNA networks in ovaries of DHEA induced PCOS rats.
    Li T; Zhang T; Gao H; Wang H; Yan H; Wan Z; Liu R; Yin C
    J Steroid Biochem Mol Biol; 2023 Feb; 226():106175. PubMed ID: 36374793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome.
    Jiao J; Shi B; Wang T; Fang Y; Cao T; Zhou Y; Wang X; Li D
    Hum Reprod; 2018 Sep; 33(9):1735-1748. PubMed ID: 30052945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of ncRNAs as ceRNAs in Gastric Cancer.
    Ye J; Li J; Zhao P
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNAs: Emerging Modulators in the Pathophysiology of Polycystic Ovary Syndrome and their Clinical Implications.
    Mazloomi S; Mousavi V; Aghadavod E; Mafi A
    Curr Mol Med; 2024; 24(2):153-166. PubMed ID: 36627779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.
    Zeng Z; Lin X; Xia T; Liu W; Tian X; Li M
    Biomed Res Int; 2020; 2020():1817094. PubMed ID: 33224973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.